Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Accounts Payable & Accrued Expense : ¥3,132 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Accounts Payable & Accrued Expense?

Shijiazhuang Yiling Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥3,256 Mil) to Dec. 2023 (¥3,341 Mil) but then declined from Dec. 2023 (¥3,341 Mil) to Mar. 2024 (¥3,132 Mil).

Shijiazhuang Yiling Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,929 Mil) to Dec. 2022 (¥3,035 Mil) and increased from Dec. 2022 (¥3,035 Mil) to Dec. 2023 (¥3,341 Mil).

Shijiazhuang Yiling Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

710.18

1,585.63

1,928.73

3,034.84

3,340.79

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,474.87	4,200.06	3,256.31	3,340.79	3,131.50

Shijiazhuang Yiling Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN

Website

http://www.yiling.cn/

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Executives

Zhang Qiu Lian	Directors, executives
Han Yue Zhi	Executives
Zhao Shao Hua	Executives
Wang Wei	Executives
Gao Xue Dong	Supervisors
Wu Yi Ling	Director
Gao Xiu Qiang	Executives
Wu Xiang Jun	Directors, executives
Guo Shuang Geng	Director
Wang Hua	Securities Affairs Representative
Dai Feng Xiang	Directors, executives
Liu Gen Wu	Supervisors
Wang Wei Ping	Directors, executives
Xu Wei Dong	Director
Wu Rui	Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines